Vered Heffes

发表

Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse

N. Goldschmidt, M. Gatt, E. Dann, 2019, Leukemia & lymphoma.

Intermediate Dose Methotrexate Improves Overall Survival and Progression-Free Survival of Patients with Diffuse Large B Cell Lymphoma Treated with the R-CHOP or CHOP Regimen

I. Avivi, E. Dann, N. Benyamini, 2015 .